Results 61 to 70 of about 61,140 (175)

Positron Emission Mammography Imaging with Low Activity Fluorodeoxyglucose and Novel Utilization in Core-needle Biopsy Sampling

open access: yesWorld Journal of Nuclear Medicine, 2015
Positron emission mammography (PEM), a relatively novel breast imaging modality, provides certain advantages over magnetic resonance imaging, including the ability to image biopsy samples.
Sadia Choudhery, Stephen Seiler
doaj   +1 more source

Segmentation-Free Outcome Prediction from Head and Neck Cancer PET/CT Images: Deep Learning-Based Feature Extraction from Multi-Angle Maximum Intensity Projections (MA-MIPs) [PDF]

open access: yesCancers. 2024; 16(14):2538
We introduce an innovative, simple, effective segmentation-free approach for outcome prediction in head \& neck cancer (HNC) patients. By harnessing deep learning-based feature extraction techniques and multi-angle maximum intensity projections (MA-MIPs) applied to Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) volumes, our proposed method ...
arxiv   +1 more source

Brown adipose activation and reversible beige coloration in adipose tissue with multiple accumulations of 18F‐fluorodeoxyglucose in sporadic paraganglioma: A case report

open access: yesClinical Case Reports, 2019
In pheochromocytoma/paraganglioma, nontumorous high 18F‐fluorodeoxyglucose accumulations are observed in both beige and brown adipose tissues. Recognizing this feature of 18F‐fluorodeoxyglucose accumulation can help physicians make precise diagnoses and ...
Eriko Terada   +5 more
doaj   +1 more source

The Use of Positron Emission Tomography in Soft Tissue Sarcoma Patients under Therapy with Trabectedin

open access: yesMarine Drugs, 2009
Background: We used 2-deoxy-2-[18F] fluoro-D-glucose (FDG) positron emission tomography (PET) to evaluate the FDG uptake in patients with advanced and/or metastatic soft tissue sarcoma (STS) undergoing therapy with Ecteinascidin-743 (ET-743, Trabectedin,
Gerlinde Egerer   +5 more
doaj   +1 more source

The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to tyrosine-kinase inhibitors in patients with metastatic primary renal cell carcinoma

open access: yesRadiology and Oncology, 2014
Background. Positron emission tomography-computed tomography (PET-CT) using fluorodeoxyglucose (FDG) is increasingly used in the evaluation of patients with advanced renal cell carcinoma (RCC), primarily for staging purposes.
Caldarella Carmelo   +5 more
doaj   +1 more source

18F-FDG PET/CT imaging in pulmonary sarcomatoid carcinoma

open access: yesFrontiers in Oncology
BackgroundPulmonary sarcomatoid carcinoma (PSC) is a rare highly aggressive and poorly differentiated non-small cell carcinoma, and little is known about the information on the usefulness of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography ...
Zhe-Huang Luo   +3 more
doaj   +1 more source

Prediction of improvement of ventricular function after revascularization: 18F-fluorodeoxyglucose single-photon emission computed tomography vs low-dose dobutamine echocardiography [PDF]

open access: bronze, 1997
Jan H. Cornel   +8 more
openalex   +1 more source

The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma [PDF]

open access: bronze, 1998
Vinita Ahuja   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy